Premier Li Keqiang delivered his annual Government Work Report at the “Two Sessions” meeting, which includes the National People’s Congress and commenced this week in Beijing. The report highlighted significant economic and social advancements, reflecting the government’s efforts in various sectors.<\/p>\n\n\n\n
Economic Highlights<\/strong> Healthcare Initiatives<\/strong>
During 2022, China’s national GDP reached RMB 121 trillion (USD 17.47 trillion), with an average annual growth rate of 5.2% over the last five years. The government generated RMB 20.4 trillion (USD 2.94 trillion) in fiscal revenues, alongside industrial added-value exceeding RMB 40 trillion (USD 5.77 trillion). The national research and development (R&D) intensity increased from 2.1% to more than 2.5%, demonstrating a continued drive towards innovation across industries.<\/p>\n\n\n\n
In the healthcare sector, the government intensified efforts on basic medical insurance (BMI) and major illness insurance. The per capita financial subsidy for urban and rural BMI residents was raised from RMB 450 to RMB 610 (USD 65 to 88), with more drugs included on the National Reimbursement Drug List (NRDL). The inter-provincial direct settlement system for both hospitalization and outpatient expenses has benefited over 67 million people. The volume-based procurement (VBP) program for drugs and medical consumables resulted in savings of RMB 400 billion (USD 57.77 billion) for citizens. Thirteen national medical centers were established last year, with 76 national regional medical centers in development. Public hospitals underwent comprehensive reforms, county medical care capabilities were enhanced, and tiered diagnosis and treatment systems were expanded. Traditional Chinese medicine received increased support, and the per capita financial subsidy standard for basic public health services was raised from RMB 50 to RMB 84 (USD 7.22 to 12.13). The disease prevention and control system was also reformed and improved.<\/p>\n\n\n\n